Does gadolinium truly enhance the active surveillance of men with prostate cancer?

Does gadolinium truly enhance the active surveillance of men with prostate cancer?Active surveillance (AS) is the preferred management of low-risk prostate cancer (PCa) and has expanded to some favourable intermediaterisk cases, and multiparametric MRI (mpMRI) plays a significant role in monitoring patients who are on surveillance.However, widespread adoption of serial mpMRI is challenging because of resource constraints and increased demand for prostate MRI.Biparametric MRI (bpMRI) omits the gadolinium-based dynamic contrast-enhanced (DCE) phase, retaining only the T2-weighted and diffusion-weighted